Literature DB >> 24333259

Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study.

Ralph Michael1, Cees Otto2, Aufried Lenferink2, Ellen Gelpi3, Gustavo A Montenegro4, Jurja Rosandić4, Francisco Tresserra5, Rafael I Barraquer4, Gijs F J M Vrensen6.   

Abstract

We have compared the protein profiles in plaques and tangles in the hippocampus of post-mortem Alzheimer brains and in opaque and clear regions in the deep cortex of eye lenses of the same donors. From the 7 Alzheimer donors studied, 1 had pronounced bilateral cortical lens opacities, 1 moderate and 5 only minor or no cortical opacities. We focused on beta-sheet levels, a hallmarking property of amyloid-beta, the major protein of plaques and tau protein, the major protein of tangles in Alzheimer brains. Confocal Raman microspectroscopy and imaging was used in combination with hierarchical cluster analysis. Plaques and tangles show high levels of beta-sheets with a beta-sheet to protein ratio of 1.67. This ratio is 1.12 in unaffected brain tissue surrounding the plaques and tangles. In the lenses this ratio is 1.17 independently of the presence or absence of opacities. This major difference in beta-sheet conformation between hippocampus and lens is supported by Congo red and immunostaining of amyloid-beta and tau which were positive for plaques and tangles in the hippocampus but fully negative for the lens irrespective of the presence or absence of opacities. In line with a previous study (Michael et al., 2013) we conclude that cortical lens opacities are not typical for Alzheimer patients and are not hallmarked by accumulation of amyloid-beta, and can thus not be considered as predictors or indicators of Alzheimer disease as claimed by Goldstein et al. (2003).
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer; Raman spectroscopy; amyloid-beta; brain; cataract; hippocampus; lens

Mesh:

Substances:

Year:  2013        PMID: 24333259     DOI: 10.1016/j.exer.2013.11.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  15 in total

Review 1.  At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Authors:  Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang
Journal:  Alzheimers Dement       Date:  2014-07-09       Impact factor: 21.566

Review 2.  Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.

Authors:  T M Shah; S M Gupta; P Chatterjee; M Campbell; R N Martins
Journal:  Mol Psychiatry       Date:  2017-01-17       Impact factor: 15.992

3.  Three-dimensional visualization of opacifications in the murine crystalline lens by in vivo optical coherence tomography.

Authors:  Pablo Eugui; Danielle J Harper; Stefan Kummer; Antonia Lichtenegger; Johanna Gesperger; Tanja Himmel; Marco Augustin; Conrad W Merkle; Martin Glösmann; Bernhard Baumann
Journal:  Biomed Opt Express       Date:  2020-03-19       Impact factor: 3.732

4.  A test of lens opacity as an indicator of preclinical Alzheimer Disease.

Authors:  Ling Bei; Ying-Bo Shui; Fang Bai; Suzanne K Nelson; Gregory P Van Stavern; David C Beebe
Journal:  Exp Eye Res       Date:  2015-03-13       Impact factor: 3.467

Review 5.  The Eye As a Biomarker for Alzheimer's Disease.

Authors:  Jeremiah K H Lim; Qiao-Xin Li; Zheng He; Algis J Vingrys; Vickie H Y Wong; Nicolas Currier; Jamie Mullen; Bang V Bui; Christine T O Nguyen
Journal:  Front Neurosci       Date:  2016-11-17       Impact factor: 4.677

Review 6.  Current and Emerging Technologies for Probing Molecular Signatures of Traumatic Brain Injury.

Authors:  Ari Ercole; Sandra Magnoni; Gloria Vegliante; Roberta Pastorelli; Jakub Surmacki; Sarah Elizabeth Bohndiek; Elisa R Zanier
Journal:  Front Neurol       Date:  2017-08-30       Impact factor: 4.003

7.  Hyperspectral Raman imaging of neuritic plaques and neurofibrillary tangles in brain tissue from Alzheimer's disease patients.

Authors:  Ralph Michael; Aufried Lenferink; Gijs F J M Vrensen; Ellen Gelpi; Rafael I Barraquer; Cees Otto
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

Review 8.  Protein and Imaging Biomarkers in the Eye for Early Detection of Alzheimer's Disease.

Authors:  Shaunt Fereshetian; Joshua S Agranat; Nicole Siegel; Steven Ness; Thor D Stein; Manju L Subramanian
Journal:  J Alzheimers Dis Rep       Date:  2021-05-03

Review 9.  Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression.

Authors:  Fatimah Zara Javaid; Jonathan Brenton; Li Guo; Maria F Cordeiro
Journal:  Front Neurol       Date:  2016-04-19       Impact factor: 4.003

10.  The eye lens: age-related trends and individual variations in refractive index and shape parameters.

Authors:  Barbara Pierscionek; Mehdi Bahrami; Masato Hoshino; Kentaro Uesugi; Justyn Regini; Naoto Yagi
Journal:  Oncotarget       Date:  2015-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.